Cytosorbents Statistics
NASDAQ: CTSOHealth CareMedical/Dental InstrumentsUSD
3.75+0.02 (+0.54%)
Market open · Delayed 15 min · as of Oct 9, 12:27 PM ET
Cytosorbents by the numbers
Cytosorbents has a market capitalization of $11.8 million based on 3.15M shares outstanding. With trailing EPS of $-5.80, Cytosorbents is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 39.6% below its 50-day average and 63.3% below its 200-day average.
Average daily trading volume is 12.45K shares, or about $46,699 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CTSO valuation vs. peer median
| Metric | CTSO | Peer median | Difference |
|---|---|---|---|
| Market cap | $11.82M | $9.89M | +20% |
| Avg. volume | 12.45K | 395.12K | -97% |
Peer median across 8 companies: PLSM, NMTC, AEMD, SINT, TNON, CNSY, CODX, WOK.
Valuation
- Market cap
- $11.82M
- EPS (TTM)
- $-5.80
- Shares outstanding
- 3.15M
Price and trading
- Previous close
- 3.73
- Open
- 3.67
- Day range
- 3.67 – 3.80
- 52-week range
- 3.66 – 19.72
- 52-week change
- -80.87%
- Beta
- —
- Volume
- 2.92K
- Average volume
- 12.45K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 6, 2026
Additional statistics
- Market Cap
- 11.82M
- Eps
- -5.80
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 19.72
- Week52 Low
- 3.66
- Avg Volume
- 12,453.00
- Shares Outstanding
- 3.15M
- Ma50
- 6.21
- Ma200
- 10.23
- Earnings Date
- Aug 6, 2026
- Pct From52w High
- -80.98%
- Pct From52w Low
- 2.46%